Feature

Medical marijuana’s ‘Catch-22’: Federal limits on research hinder patients’ relief


 


Without clear answers, hospitals, doctors, and patients are left to their own devices, which can result in poor treatment and needless suffering.

Hospitals and other medical facilities have to decide what to do with newly hospitalized patients who normally take medical marijuana at home.

Some have a “don’t ask, don’t tell” approach, said Dr. Devinsky, who sometimes advises his patients to use it. Others ban its use and substitute opioids or other prescriptions.

Young adults, for instance, have had to stop taking cannabidiol compounds for their epilepsy because they’re in federally funded group homes, said Dr. Devinsky, the director of New York University’s Langone Comprehensive Epilepsy Center.

“These kids end up getting seizures again,” he said. “This whole situation has created a hodgepodge of insanity.”

Pages

Recommended Reading

Mortality rate was 10-fold higher in opioid use disorder patients
MDedge Infectious Disease
The latest news on pediatric migraine
MDedge Infectious Disease
‘Chronic Lyme’: Serious bacterial infections reported with unproven treatments
MDedge Infectious Disease
Adjuvant-boosted shingles vaccine earns FDA panel’s unanimous nod
MDedge Infectious Disease
Post-Ebola syndrome includes neurologic sequelae
MDedge Infectious Disease
In close vote, advisory panel prefers Shingrix over Zostavax
MDedge Infectious Disease
Novel herpes zoster vaccine is more cost effective than old vaccine
MDedge Infectious Disease
MDedge Daily News: Why the barber’s chair can help hypertension
MDedge Infectious Disease
MDedge Daily News: Does more marijuana mean fewer opioids?
MDedge Infectious Disease
Life and health are not even across the U.S.
MDedge Infectious Disease